HEADER SPLICING 13-NOV-13 4NL6 OBSLTE 12-OCT-16 4NL6 NONE TITLE STRUCTURE OF THE FULL-LENGTH FORM OF THE PROTEIN SMN FOUND IN HEALTHY TITLE 2 PATIENTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: SURVIVAL MOTOR NEURON PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: SMN, COMPONENT OF GEMS 1, GEMIN-1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMN1, SMN, SMNT, SMN2, SMNC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA-BETA PROTEIN, RNA METABOLISM, SPLICEOSOMES, SPLICING EXPDTA X-RAY DIFFRACTION MDLTYP CA ATOMS ONLY, CHAIN A, B, C AUTHOR J.P.ALLEN,C.SENG REVDAT 3 12-OCT-16 4NL6 1 OBSLTE REVDAT 2 01-APR-15 4NL6 1 JRNL HELIX SHEET REVDAT 1 21-JAN-15 4NL6 0 JRNL AUTH C.O.SENG,C.MAGEE,P.J.YOUNG,C.L.LORSON,J.P.ALLEN JRNL TITL THE SMN STRUCTURE REVEALS ITS CRUCIAL ROLE IN SNRNP JRNL TITL 2 ASSEMBLY. JRNL REF HUM.MOL.GENET. V. 24 2138 2015 JRNL REFN ISSN 0964-6906 JRNL PMID 25561692 JRNL DOI 10.1093/HMG/DDU734 REMARK 2 REMARK 2 RESOLUTION. 5.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 5.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 5.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 48.3 REMARK 3 NUMBER OF REFLECTIONS : 2361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.301 REMARK 3 R VALUE (WORKING SET) : 0.299 REMARK 3 FREE R VALUE : 0.342 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 111 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 8.9846 - 5.5000 0.48 2250 111 0.2989 0.3415 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.800 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6633 REMARK 3 ANGLE : 1.452 9049 REMARK 3 CHIRALITY : 0.051 945 REMARK 3 PLANARITY : 0.011 1251 REMARK 3 DIHEDRAL : 16.864 2531 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NON-CA ATOMS HAVE BEEN REMOVED POST- REMARK 3 REFINEMENT. REMARK 4 REMARK 4 4NL6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 5 REMARK 5 THIS ENTRY IS FROM THE WRONG SAMPLE AND WAS WITHDRAWN AT THE REMARK 5 REQUEST OF THE AUTHOR. REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-13. REMARK 100 THE RCSB ID CODE IS RCSB083341. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4512 REMARK 200 RESOLUTION RANGE HIGH (A) : 5.500 REMARK 200 RESOLUTION RANGE LOW (A) : 90.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 61.3 REMARK 200 DATA REDUNDANCY : 3.030 REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 5.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 5.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.91 REMARK 200 R MERGE FOR SHELL (I) : 0.36400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 1MHN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 76.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:1 PROTEIN TO 1.8 M AMMONIUM SULFATE, REMARK 280 0.1 M MES, PH 6.5, 0.01 M COBALT CHLORIDE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 68.52050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 84.91150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 68.52050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 84.91150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU C 293 REMARK 465 ASN C 294 REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NL7 RELATED DB: PDB DBREF 4NL6 A 1 294 UNP Q16637 SMN_HUMAN 1 294 DBREF 4NL6 B 1 294 UNP Q16637 SMN_HUMAN 1 294 DBREF 4NL6 C 1 294 UNP Q16637 SMN_HUMAN 1 294 SEQRES 1 A 294 MET ALA MET SER SER GLY GLY SER GLY GLY GLY VAL PRO SEQRES 2 A 294 GLU GLN GLU ASP SER VAL LEU PHE ARG ARG GLY THR GLY SEQRES 3 A 294 GLN SER ASP ASP SER ASP ILE TRP ASP ASP THR ALA LEU SEQRES 4 A 294 ILE LYS ALA TYR ASP LYS ALA VAL ALA SER PHE LYS HIS SEQRES 5 A 294 ALA LEU LYS ASN GLY ASP ILE CYS GLU THR SER GLY LYS SEQRES 6 A 294 PRO LYS THR THR PRO LYS ARG LYS PRO ALA LYS LYS ASN SEQRES 7 A 294 LYS SER GLN LYS LYS ASN THR ALA ALA SER LEU GLN GLN SEQRES 8 A 294 TRP LYS VAL GLY ASP LYS CYS SER ALA ILE TRP SER GLU SEQRES 9 A 294 ASP GLY CYS ILE TYR PRO ALA THR ILE ALA SER ILE ASP SEQRES 10 A 294 PHE LYS ARG GLU THR CYS VAL VAL VAL TYR THR GLY TYR SEQRES 11 A 294 GLY ASN ARG GLU GLU GLN ASN LEU SER ASP LEU LEU SER SEQRES 12 A 294 PRO ILE CYS GLU VAL ALA ASN ASN ILE GLU GLN ASN ALA SEQRES 13 A 294 GLN GLU ASN GLU ASN GLU SER GLN VAL SER THR ASP GLU SEQRES 14 A 294 SER GLU ASN SER ARG SER PRO GLY ASN LYS SER ASP ASN SEQRES 15 A 294 ILE LYS PRO LYS SER ALA PRO TRP ASN SER PHE LEU PRO SEQRES 16 A 294 PRO PRO PRO PRO MET PRO GLY PRO ARG LEU GLY PRO GLY SEQRES 17 A 294 LYS PRO GLY LEU LYS PHE ASN GLY PRO PRO PRO PRO PRO SEQRES 18 A 294 PRO PRO PRO PRO PRO HIS LEU LEU SER CYS TRP LEU PRO SEQRES 19 A 294 PRO PHE PRO SER GLY PRO PRO ILE ILE PRO PRO PRO PRO SEQRES 20 A 294 PRO ILE CYS PRO ASP SER LEU ASP ASP ALA ASP ALA LEU SEQRES 21 A 294 GLY SER MET LEU ILE SER TRP TYR MET SER GLY TYR HIS SEQRES 22 A 294 THR GLY TYR TYR MET GLY PHE ARG GLN ASN GLN LYS GLU SEQRES 23 A 294 GLY ARG CYS SER HIS SER LEU ASN SEQRES 1 B 294 MET ALA MET SER SER GLY GLY SER GLY GLY GLY VAL PRO SEQRES 2 B 294 GLU GLN GLU ASP SER VAL LEU PHE ARG ARG GLY THR GLY SEQRES 3 B 294 GLN SER ASP ASP SER ASP ILE TRP ASP ASP THR ALA LEU SEQRES 4 B 294 ILE LYS ALA TYR ASP LYS ALA VAL ALA SER PHE LYS HIS SEQRES 5 B 294 ALA LEU LYS ASN GLY ASP ILE CYS GLU THR SER GLY LYS SEQRES 6 B 294 PRO LYS THR THR PRO LYS ARG LYS PRO ALA LYS LYS ASN SEQRES 7 B 294 LYS SER GLN LYS LYS ASN THR ALA ALA SER LEU GLN GLN SEQRES 8 B 294 TRP LYS VAL GLY ASP LYS CYS SER ALA ILE TRP SER GLU SEQRES 9 B 294 ASP GLY CYS ILE TYR PRO ALA THR ILE ALA SER ILE ASP SEQRES 10 B 294 PHE LYS ARG GLU THR CYS VAL VAL VAL TYR THR GLY TYR SEQRES 11 B 294 GLY ASN ARG GLU GLU GLN ASN LEU SER ASP LEU LEU SER SEQRES 12 B 294 PRO ILE CYS GLU VAL ALA ASN ASN ILE GLU GLN ASN ALA SEQRES 13 B 294 GLN GLU ASN GLU ASN GLU SER GLN VAL SER THR ASP GLU SEQRES 14 B 294 SER GLU ASN SER ARG SER PRO GLY ASN LYS SER ASP ASN SEQRES 15 B 294 ILE LYS PRO LYS SER ALA PRO TRP ASN SER PHE LEU PRO SEQRES 16 B 294 PRO PRO PRO PRO MET PRO GLY PRO ARG LEU GLY PRO GLY SEQRES 17 B 294 LYS PRO GLY LEU LYS PHE ASN GLY PRO PRO PRO PRO PRO SEQRES 18 B 294 PRO PRO PRO PRO PRO HIS LEU LEU SER CYS TRP LEU PRO SEQRES 19 B 294 PRO PHE PRO SER GLY PRO PRO ILE ILE PRO PRO PRO PRO SEQRES 20 B 294 PRO ILE CYS PRO ASP SER LEU ASP ASP ALA ASP ALA LEU SEQRES 21 B 294 GLY SER MET LEU ILE SER TRP TYR MET SER GLY TYR HIS SEQRES 22 B 294 THR GLY TYR TYR MET GLY PHE ARG GLN ASN GLN LYS GLU SEQRES 23 B 294 GLY ARG CYS SER HIS SER LEU ASN SEQRES 1 C 294 MET ALA MET SER SER GLY GLY SER GLY GLY GLY VAL PRO SEQRES 2 C 294 GLU GLN GLU ASP SER VAL LEU PHE ARG ARG GLY THR GLY SEQRES 3 C 294 GLN SER ASP ASP SER ASP ILE TRP ASP ASP THR ALA LEU SEQRES 4 C 294 ILE LYS ALA TYR ASP LYS ALA VAL ALA SER PHE LYS HIS SEQRES 5 C 294 ALA LEU LYS ASN GLY ASP ILE CYS GLU THR SER GLY LYS SEQRES 6 C 294 PRO LYS THR THR PRO LYS ARG LYS PRO ALA LYS LYS ASN SEQRES 7 C 294 LYS SER GLN LYS LYS ASN THR ALA ALA SER LEU GLN GLN SEQRES 8 C 294 TRP LYS VAL GLY ASP LYS CYS SER ALA ILE TRP SER GLU SEQRES 9 C 294 ASP GLY CYS ILE TYR PRO ALA THR ILE ALA SER ILE ASP SEQRES 10 C 294 PHE LYS ARG GLU THR CYS VAL VAL VAL TYR THR GLY TYR SEQRES 11 C 294 GLY ASN ARG GLU GLU GLN ASN LEU SER ASP LEU LEU SER SEQRES 12 C 294 PRO ILE CYS GLU VAL ALA ASN ASN ILE GLU GLN ASN ALA SEQRES 13 C 294 GLN GLU ASN GLU ASN GLU SER GLN VAL SER THR ASP GLU SEQRES 14 C 294 SER GLU ASN SER ARG SER PRO GLY ASN LYS SER ASP ASN SEQRES 15 C 294 ILE LYS PRO LYS SER ALA PRO TRP ASN SER PHE LEU PRO SEQRES 16 C 294 PRO PRO PRO PRO MET PRO GLY PRO ARG LEU GLY PRO GLY SEQRES 17 C 294 LYS PRO GLY LEU LYS PHE ASN GLY PRO PRO PRO PRO PRO SEQRES 18 C 294 PRO PRO PRO PRO PRO HIS LEU LEU SER CYS TRP LEU PRO SEQRES 19 C 294 PRO PHE PRO SER GLY PRO PRO ILE ILE PRO PRO PRO PRO SEQRES 20 C 294 PRO ILE CYS PRO ASP SER LEU ASP ASP ALA ASP ALA LEU SEQRES 21 C 294 GLY SER MET LEU ILE SER TRP TYR MET SER GLY TYR HIS SEQRES 22 C 294 THR GLY TYR TYR MET GLY PHE ARG GLN ASN GLN LYS GLU SEQRES 23 C 294 GLY ARG CYS SER HIS SER LEU ASN HELIX 1 1 PHE A 50 ILE A 59 1 10 HELIX 2 1 ASN A 137 LEU A 141 1 5 HELIX 3 1 PRO A 217 PRO A 223 10 7 HELIX 4 1 LEU A 233 PRO A 240 1 8 HELIX 5 1 CYS A 250 LEU A 254 1 5 HELIX 6 1 SER A 266 ASN A 283 1 18 HELIX 7 1 PHE B 50 ILE B 59 1 10 HELIX 8 1 ASN B 137 LEU B 141 1 5 HELIX 9 1 PRO B 144 GLU B 147 1 4 HELIX 10 1 PRO B 217 PRO B 223 10 7 HELIX 11 1 LEU B 233 PRO B 240 1 8 HELIX 12 1 CYS B 250 LEU B 254 1 5 HELIX 13 1 SER B 266 ASN B 283 1 18 HELIX 14 1 PHE C 50 ILE C 59 1 10 HELIX 15 1 ASN C 137 LEU C 141 1 5 HELIX 16 1 PRO C 217 PRO C 223 10 7 HELIX 17 1 CYS C 250 LEU C 254 1 5 HELIX 18 1 SER C 266 ASN C 283 1 18 SHEET 1 A 4 GLN A 164 ARG A 174 0 SHEET 2 A 4 VAL A 19 GLY A 26 -1 SHEET 3 A 4 GLY A 64 PRO A 70 -1 SHEET 4 A 4 LYS A 97 TRP A 102 0 SHEET 5 A 4 GLY A 106 ASP A 117 -1 SHEET 6 A 4 THR A 122 TYR A 127 -1 SHEET 7 A 4 GLY A 131 ASN A 137 -1 SHEET 8 A 4 ASN A 178 LYS A 184 -1 SHEET 1 B 4 GLN B 164 ARG B 174 0 SHEET 2 B 4 VAL B 19 GLY B 26 -1 SHEET 3 B 4 GLY B 64 PRO B 70 -1 SHEET 4 B 4 LYS B 97 TRP B 102 0 SHEET 5 B 4 GLY B 106 ASP B 117 -1 SHEET 6 B 4 THR B 122 TYR B 127 -1 SHEET 7 B 4 GLY B 131 ASN B 137 -1 SHEET 8 B 4 ASN B 178 LYS B 184 -1 SHEET 1 C 4 GLN C 164 ARG C 174 0 SHEET 2 C 4 VAL C 19 GLY C 26 -1 SHEET 3 C 4 GLY C 64 PRO C 70 -1 SHEET 4 C 4 LYS C 97 TRP C 102 0 SHEET 5 C 4 GLY C 106 ASP C 117 -1 SHEET 6 C 4 THR C 122 TYR C 127 -1 SHEET 7 C 4 GLY C 131 ASN C 137 -1 SHEET 8 C 4 ASN C 178 LYS C 184 -1 CRYST1 137.041 169.823 108.787 90.00 128.54 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007297 0.000000 0.005813 0.00000 SCALE2 0.000000 0.005888 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011752 0.00000